Kandoset (Amlodipine, Candesartan Cilexetil)

• Kandoset is used to manage hypertension, a condition characterized by elevated arterial pressure.
• Hypertension: lowers systolic and diastolic blood pressure by combining calcium channel blockade with angiotensin II receptor antagonism.

• Amlodipine blocks L-type calcium channels in vascular smooth muscle, causing vasodilation and reduced peripheral resistance. Candesartan selectively antagonizes AT1 receptors for angiotensin II, preventing vasoconstriction and aldosterone release. The dual action produces additive blood pressure reduction through complementary pathways.

Common Side Effects

• Headache: mild to moderate pain often occurring early in therapy.
• Peripheral edema: swelling of the lower limbs due to fluid accumulation.
• Dizziness or light‑headedness: related to blood pressure lowering.
• Flushing: transient warmth and redness of the skin.
• Fatigue: general feeling of tiredness.
• Nausea: mild gastrointestinal discomfort.

Serious or Rare Side Effects

• Angioedema: rapid swelling of face, lips, tongue, or airway requiring emergency care.
• Severe hypotension: dangerously low blood pressure with fainting risk.
• Hepatic dysfunction: abnormal liver enzymes or hepatitis.
• Myocardial infarction: rare occurrence of heart attack.
• Renal impairment: worsening kidney function.
• Allergic reactions: rash, itching, or anaphylaxis.

Before initiating therapy, consider the following precautions:

• Monitor blood pressure: check regularly to assess efficacy and avoid excessive lowering.
• Assess renal function: adjust use if significant renal impairment is present.
• Avoid in severe aortic stenosis: contraindicated due to risk of hypotension.
• Caution in hepatic impairment: may require dose modification.
• Pregnancy and lactation: use only if benefits outweigh potential risks.
• Store at ambient temperature: keep in the original container, protect from moisture and light.

Kandoset may interact with several medicines; awareness helps maintain safety.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma concentrations.
• Concurrent use of other antihypertensives: risk of excessive hypotension.
• Potassium‑sparing diuretics or supplements: can raise serum potassium levels.
• Lithium: increased risk of lithium toxicity.

Moderate Interactions (Monitor Closely)

• NSAIDs: may diminish antihypertensive effect.
• Rifampin or other enzyme inducers: may lower drug concentrations.
• Loop or thiazide diuretics: may affect electrolyte balance.